Insomnia

Expert perspectives on the benefits of and limitations to cognitive behavioral therapy for insomnia.

Focusing on treatment options for insomnia, experts consider the added value of sleep hygiene.

The treatment yielded significant improvements for sleep onset and sleep maintenance.

Panelists discuss the broad range of impact insomnia has on a patient’s health and quality of life.

A brief review of the value of polysomnography, or sleep studies, in diagnosing patients with insomnia.

Considerations for how to optimally work up and diagnose patients with insomnia.

A panel of experts break down the myriad of insomnia causes, discussing prevalence amid different patient populations.

Shared insight on how daytime functioning has become part of the insomnia treatment paradigm.

The dual orexin receptor antagonist notably demonstrates a positive benefit-risk balance for patients

Data show zolpidem use in 8-week insomnia trial reduced suicidal ideation in patients, even after trial randomization ended.

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

Both telemedicine and face-to-face therapy resulted in improved daytime function.

New research finds a 13% higher mortality rate for every 5% reduction in REM sleep.

Shorter nighttime sleep duration and later bedtime at 3.5 years old age were significantly associated with borderline personality disorder symptoms.

The presence of anxiety symptoms moderated most alterations in emotional processing observed following sleep restriction.

Recently, there has been a 7% increase in cannabis use from pregnant mothers.

Dr. Jennifer Martin explains how teenagers could benefit from a better sleep schedule and a later wake up time.

Increased technology use and alcohol consumption may be leading to some troubling trends in sleep.

The researchers suggested a significant link between second-hand smoke exposure and poor sleep quality, particularly among adolescents.

Individuals at 15 years old with depression experience struggles with both sleep patterns and sleep quality.

ADHD symptoms are highly comorbid with insomnia, restless leg syndrome, and snoring.

Sirimon Reutrakul, MD, discusses what providers should do based on the findings of a new study presented at ADA 2020.

Recent studies show efficacy and safety for both lemborexant and ozanimod.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.